Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies*-Reference-Cited by-同舟云学术

Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies*

Published:1997-05-01 Issue:5 Volume:82 Page:1572-1581
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Kwong Linda K.¹,Ridinger David N.¹,Bandhauer Michael¹,Ward John H.¹,Samlowski Wolfram E.¹,Iverius Per-Henrik¹,Pritchard Haydn¹,Wilson Dana E.¹

Affiliation:

1. Veterans Affairs Medical Center and the Department of Internal Medicine, Division of Endocrinology, Metabolism, and Diabetes and the Division of Hematology and Oncology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84132; and University of British Columbia, Vancouver, British Columbia, Canada V6T 1Z4

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/82/5/1572/9042406/jcem1572.pdf

Reference52 articles.

1. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.;Rosenberg;N Engl J Med,1987

2. Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

3. Interleukin-2 induces a profound reversible cholestasis: a detailed analysis in treated cancer patients.;Fisher;J Clin Oncol,1989

4. Modification of plasma lipids, lipoproteins, and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells.;Malmendier;Atherosclerosis,1988